Evidence map›Paper›PMID 41004471›Full record

ArticlePloS one2025

Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models.

Fatima Zahra Rhmari Tlemçani, Faiçal Aitlahbib, Soukaina Laidi, Najib Alidrissi, Jehanne Aasfara, Saloua Elamari, Asma Chadli, Imane Motaib

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatima Zahra Rhmari TlemçaniFaculty of Medicine, Laboratory of genomics, Epigenetics, Personalized and Predictive Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Faiçal AitlahbibInnovx, Mohammed VI Polytechnic University, Benguerir, Morocco.
Soukaina LaidiDepartment of Endocrinology Diabetology Metabolic Disease and Nutrition, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Najib AlidrissiFaculty of Medicine, Laboratory of genomics, Epigenetics, Personalized and Predictive Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.ORCID 0000-0001-6872-7060
Jehanne AasfaraFaculty of Medicine, Laboratory of genomics, Epigenetics, Personalized and Predictive Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.ORCID 0000-0003-0318-5816
Saloua ElamariDepartment of Endocrinology Diabetology Metabolic Disease and Nutrition, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Asma ChadliDepartment of Endocrinology Diabetology Metabolic Disease and Nutrition, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Imane MotaibFaculty of Medical Sciences, UM6P Hospitals, Mohammed VI Polytechnic University, Benguerir, Morocco.ORCID 0000-0002-8426-3929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mild cognitive impairment (MCI) is a significant and increasingly recognized problem in individuals with type 2 diabetes mellitus (T2DM). This study aims to develop a machine-learning model to predict MCI in patients with T2DMThe dataset was obtained from a prospective cohort conducted at the Sheikh Khalifa Ibn Zaid Hospital, Casablanca, Morocco, and was randomly split into three parts. Machine learning models were trained using the training dataset, and their performance was assessed on the test dataset. The unseen data was reserved for final validation. Subsequently, recursive feature elimination was applied with the top two algorithms to identify and retain the most impactful features for predicting MCI. Then, we retrained the models using the selected variables. Finally, the variables most contributing to the prediction of MCI were represented in a Shapley Additive Explanations SHAPE value plot to better understand their contribution and their ranking in MCI prediction.The dataset included 100 patients. Extra Trees classifier was the best-performing model for mild cognitive impairment (Accuracy: 0·9310/AUC: 0·9667/ Recall: 0·9333/ Precision: 0·9333/F1: 0·9333). The most contributing factors to MCI in patients with type 2 diabetes were, respectively, diabetic retinopathy, age, serum LDL cholesterol level, microalbuminuria, HbA1c, and, serum creatinine level. Our findings suggest avenues for early intervention that could prevent the progression of cognitive impairment among patients with type 2 diabetes.

Indexed as

Cognitive DysfunctionDiabetes Mellitus, Type 2Diabetic RetinopathyMachine LearningAgedFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID41004471
PMCPMC12468980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.